The United States Food and Drug Administration (FDA) has approved a new non-opioid prescription medication, Journavx ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...

The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid ...

CenExel, a leading network of clinical research sites, proudly congratulates and announces its role in supporting Vertex Pharmaceuticals’ clinical studies that led to the FDA approval of JOURNAVX™ ...

The drug, Journavx, or suzetrigine, was approved to treat moderate to severe acute, or short-term, pain in adults. Experts ...

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...